University of Edinburgh College of Medicine and Veterinary Medicine

The Galien Foundation Presents 2023 Prix Galien UK Awards at the Natural History Museum, London

Retrieved on: 
Friday, May 12, 2023
University, College, Saint George, Consultant, University of Edinburgh College of Medicine and Veterinary Medicine, Innovation, Research, University of Liverpool, Digital health, World Health Organization, Chandos Chair of Medicine and Anatomy, University of Edinburgh, Imperial College London, NHS trust, Senior advisor, Therapy, Veterinary medicine, Respiratory Medicine, Pharmaceutical industry, Management, Medicine

LONDON, May 12, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, announced winners for the 2023 Prix Galien UK Awards last night at the Natural History Museum, London. Awards for "Best Biotechnology Product," "Best Pharmaceutical Product," "Best Medical Technology" and "Best Digital Health Solution" were awarded to industry leaders dedicated to innovation that improves the human condition. A winner was also announced in the newest award category, "Best Public Sector Innovation," to recognise innovations that are funded and driven by the UK government via the NHS and not-for-profit organisations.

Key Points: 
  • "The Prix Galien Awards Committee, who reviewed this year's candidates and selected the award winners, were inspired by the work of the teams behind these innovations, which were developed to prevent, treat, and cure diseases," said Professor Sir Mark Walport, Honorary Distinguished Professor of Medicine, Imperial College, and Prix Galien UK Committee Chair.
  • "Congratulations to our winners and all award candidates, and thank you for your continued dedication to research and its applications for health improvement."
  • Honorary Distinguished Professor of Medicine, Imperial College, London UK
    Chair, NICE Technology Appraisal Committee and Consultant, St. George's NHS Trust Professor
    Health Technology Director, Senior Consultant, Hardian Health & Senior Adviser and Consultant, World Health Organization's Department of Digital Health and Innovation
    David Weatherall Chair of Medicine, University of Liverpool, Liverpool
    Christison Chair of Therapeutics & Clinical Pharmacology, University of Edinburgh
    Vice Principal and Head of the College of Medicine and Veterinary Medicine, Sir John Crofton Professor of Respiratory Medicine, University of Edinburgh

The Galien Foundation Announces 2023 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product" and Newly Added, "Best Public Sector Innovation"

Retrieved on: 
Tuesday, May 2, 2023
ER, University, College, Saint George, HER2, Consultant, University of Edinburgh College of Medicine and Veterinary Medicine, Innovation, Committee, University of Liverpool, The Committee, Digital health, World Health Organization, Chandos Chair of Medicine and Anatomy, University of Edinburgh, Imperial College London, NHS trust, Senior advisor, NHS, Health, Therapy, PPIE, Veterinary medicine, Respiratory Medicine, PR, Pharmaceutical industry, Management, Medicine

LONDON, May 2, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2023 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," and "Best Pharmaceutical Product." Candidates have also been announced for the newest Prix Galien UK Award category, "Best Public Sector Innovation," to recognise the innovations that are funded and driven by the UK government via the NHS and not-for-profit organisations. Winners will be selected by a committee of distinguished scientific leaders and announced during the Prix Galien UK Awards Ceremony, on 11 May at the Natural History Museum in London.

Key Points: 
  • Panakeia Technologies LTD (PANProfiler Breast (ER, PR, HER2) or Breast Profiler)
    Boehringer Ingelheim Uk & Ireland (New Evidence-Based PPIE guide for supporting patient-centric innovation in the NHS, with the University of Plymouth and AHSN Network)
    The Prix Galien UK Awards launched in 1990 and have been awarded to 41 products since its inception.
  • Winners are selected every two years by the Prix Galien UK Awards Committee, which comprises 14 experts in the field.
  • The Committee includes a number of the UK's leading luminaries in healthcare.
  • The distinguished panel is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health, globally.

The Galien Foundation Announces Winners of the 2022 Prix Galien UK Awards at the Natural History Museum, London

Retrieved on: 
Friday, May 13, 2022
Social media, Bill, Foundation, University of Liverpool, Health, Paganini Competition, Veterinary medicine, Therapy, Imperial College London, Edinburgh, Nobel Prize, Tropical medicine, Respiratory Medicine, Hygiene, Queen Mary University of London, Internal medicine, London School of Hygiene & Tropical Medicine, University, College, University of Edinburgh College of Medicine and Veterinary Medicine, Former, University of Edinburgh, Committee, Education, Management, Dentistry, Pharmaceutical industry, Medicine, Pediatric nursing, Biostatistics

LONDON, May 13, 2022 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, announced winners for the 2022 Prix Galien UK Awards last night at the Natural History Museum, London. Awards for "Best Biotechnology Product," "Best Pharmaceutical Product," "Best Medical Technology" and "Best Digital Health Solution" were awarded to industry leaders dedicated to innovation that improves the human condition. In conjunction with the Prix Galien UK Awards, The Galien Foundation also announced winners for the 2022 Prix Galien International Awards for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product" and "Best Vaccine."

Key Points: 
  • Former Chief Executive Officer of the Bill & Melinda Gates Foundation, Seattle, WA
    Professor of Internal Medicine and Therapeutics & Founder, Former President
    Honorary Distinguished Professor of Medicine, Imperial College, Committee Chair, Prix Galien UK Awards Committee
    The Galien Foundation fosters, recognises and rewards excellence in scientific innovation to improve the state of human health.
  • The Foundation oversees and directs activities in the UK for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa.
  • The Prix Galien was created in 1970 by Roland Mehl in honour of Galien, the father of medical science and modern pharmacology.
  • Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

The Galien Foundation Debuts 2022 Prix Galien UK Award Candidates in "Best Biotechnology Product," "Best Pharmaceutical Product," "Best Medical Technology" and "Best Digital Health Solution" Categories

Retrieved on: 
Monday, May 2, 2022
Hygiene, Education, Foundation, London School of Hygiene & Tropical Medicine, Queen Mary University of London, College, Liverpool School of Tropical Medicine, Edinburgh, Therapy, University of Liverpool, University of Edinburgh College of Medicine and Veterinary Medicine, University of Edinburgh, Veterinary medicine, Respiratory Medicine, Social media, Paganini Competition, University, Health, Nobel Prize, Dentistry, Pharmaceutical industry, Medicine, Biostatistics, Pediatric nursing

LONDON, May 2, 2022 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2022 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Pharmaceutical Product," "Best Medical Technology" and "Best Digital Health Solution." Winners will be announced during the Prix Galien UK Awards Ceremony on 12 May at the Natural History Museum in London.

Key Points: 
  • Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.
  • The Foundation oversees and directs activities in the UK for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa.
  • The Prix Galien was created in 1970 by Roland Mehl in honour of Galien, the father of medical science and modern pharmacology.
  • Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.